What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
A Look At The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)
Key Insights Using the 2 Stage Free Cash Flow to Equity, West Pharmaceutical Services fair value estimate is US$320 With US$327 share price, West Pharmaceutical Services appears to be trading
Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?
Stephens Adjusts Price Target on West Pharmaceutical Services to $400 From $420
West Pharmaceutical Services (WST) has an average outperform rating and a price target range of $336 to $470, according to analysts polled by Capital IQ.Price: 319.00, Change: -1.11, Percent Change: -
Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?
West to Host Second-Quarter 2024 Conference Call
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
What to Expect From West Pharmaceutical Services' Q2 2024 Earnings Report
Express News | West Pharmaceutical Services: New Term Loan Which Was Fully Drawn at Closing and Matures on July 2, 2027
Express News | West Pharmaceutical Services: Third Amendment Established Incremental Term Loan in Stated Principal Amount of $130.0 Mln
Express News | West Pharmaceutical Services: Third Amendment to Credit Agreement Which Amends Credit Agreement, Dated as of March 28, 2019
Does West Pharmaceutical Services (NYSE:WST) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5
EST Jun 21st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Jefferies Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $426
Jefferies analyst David Windley maintains $West Pharmaceutical Services(WST.US)$ with a buy rating, and adjusts the target price from $423 to $426.According to TipRanks data, the analyst has a success
West Pharmaceutical Services Down Over 7%, on Track for Lowest Close Since February 2023 -- Data Talk
West Pharmaceutical Services, Inc. (WST) is currently at $312.48, down $23.60 or 7.02% --Would be lowest close since Feb. 24, 2023, when it closed at $310.25 --On pace for largest percent decrease s
West Pharmaceutical Services(WST.US) Officer Sells US$595.4K in Common Stock
$West Pharmaceutical Services(WST.US)$ Officer Abraham Silji sold 1,800 shares of common stock on Jun 12, 2024 at an average price of $330.78 for a total value of $595.4K.Source: Announcement What is
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing
Silji Abraham, Senior Vice President, Chief Technology Officer, on June 12, 2024, sold 1,800 shares in West Pharmaceutical Services (WST) for $595,404. Following the Form 4 filing with the SEC, Abraha
WARF Appoints Deborah Keller Board Chair
MADISON, Wis., June 11, 2024 /PRNewswire/ -- Deborah Keller, an accomplished life sciences executive with extensive global experience in drug development, has been appointed Chair of the WARF Board o
At US$315, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?
Today we're going to take a look at the well-established West Pharmaceutical Services, Inc. (NYSE:WST). The company's stock received a lot of attention from a substantial price movement on the NYS
Peering Into West Pharmaceutical Servs's Recent Short Interest
West Pharmaceutical Servs's (NYSE:WST) short percent of float has risen 9.04% since its last report. The company recently reported that it has 1.14 million shares sold short, which is 2.05% of all reg
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to Analysts